Atrial Fibrillation in Acute Coronary Syndrome

Area of Science:

• Cardiology
• Electrophysiology
• Internal Medicine

Background:

• Atrial fibrillation (AF) is a prevalent cardiac arrhythmia affecting millions in the U.S.
• AF shares risk factors with coronary artery disease and frequently co-occurs with acute coronary syndrome (ACS) and myocardial infarction (MI).
• AF complicates approximately 10% of acute myocardial infarctions, with incidence rates consistent across different treatment eras.

Purpose of the Study:

• To review the association between atrial fibrillation and acute myocardial infarction.
• To discuss the implications of AF on mortality post-MI.
• To outline current treatment strategies for AF in the context of MI and ACS.

Main Methods:

• Literature review of studies on atrial fibrillation and acute coronary syndromes.
• Analysis of epidemiological data on AF incidence and mortality post-MI.
• Synthesis of clinical guidelines for managing AF in patients with acute cardiac events.

Main Results:

• Atrial fibrillation is a significant independent predictor of increased long-term mortality following myocardial infarction, with a relative risk of approximately 2.5.
• The incidence of AF during acute MI has remained relatively stable, around 10%, across different eras of reperfusion therapy.
• Management requires a balance between aggressive treatment of MI/ACS and AF, including anticoagulation and heart rate control, while carefully assessing bleeding risk.

Conclusions:

• Atrial fibrillation significantly increases mortality risk in patients with acute myocardial infarction.
• Urgent heart rate control and anticoagulation are crucial in managing AF concurrent with MI/ACS.
• Integrated management strategies are necessary to address the complexities of treating both conditions and mitigate bleeding risks.